Approval · Notice of Compliance 7012 · 1996
LAURABOLIN INJECTION: Notice of Compliance 7012
Issued January 3, 1996
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 7012
- Date
- January 3, 1996
- Company
- Intervet Canada CorpKirkland, Quebec, Canada
- Product type
- Veterinary
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Anabolic steroid
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| LAURABOLIN INJECTION | 02200805 | — |
Medicinal ingredients
- NANDROLONE LAURATE 25 MG per ML